Pharmacokinetics of doxycycline after administration as a single intravenous bolus and intramuscular doses to non-lactating Egyptian goats


HASSIBELNABY A. M. A., Goudah A., Zhou H.

PHARMACOLOGICAL RESEARCH, cilt.49, sa.5, ss.487-491, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 5
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1016/j.phrs.2003.10.012
  • Dergi Adı: PHARMACOLOGICAL RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.487-491
  • Atatürk Üniversitesi Adresli: Hayır

Özet

The pharmacokinetics of doxycycline hydrochloride (DoxHcl) at a dose of 5 mg kg(-1) BW was studied after an intravenous (i.v.) bolus and intramuscular (i.m.) injections in non lactating goats. A microbiological assay employing Bacillus subtilis as the test organism was used to measure its concentrations in serum and urine. Following a single i.v. injection, the serum concentration-time curves of doxycycline hydrochloride were best represented by a two-compartment open model. The drug was rapidly distributed and slowly eliminated with half-lives of distribution (t(1/2alpha)) and elimination (t(1/2beta)) of 0.52 and 4.62h, respectively. After i.m. injection of the same dose, the peak serum concentration C-max was 1.60 mug ml(-1) attained at 0.86 h (T-max). Following i.v. and i.m. injections, the concentrations of doxycycline in urine were much higher than that in serum. Urinary drug concentrations decreased gradually till reaching its lowest detectable level 12 and 24 h post-injections, respectively. The extent of serum protein binding percent was 32.8% and the systemic bioavailability was 99.40% after i.m. injection of 5 mg kg(-1) BW. (C) 2003 Elsevier Ltd. All rights reserved.